BioatlaÂ Inc (BCAB) Financials

$3.12

$-0.14 (-4.29%)

As on 26-Aug-2026 16:00EDT

Market cap

$5 Mln

Revenue (TTM)

$9 Mln

P/E Ratio

--

P/B Ratio

2.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	8.50	2.00	11.00	--	--	0.25
Cost of Revenue	8.85	43.07	0.93	1.22	1.20	58.27
Gross Profit	-0.35	-41.07	10.08	-1.22	-1.20	-58.02
Operating Expenses	31.27	18.23	84.02	128.47	106.94	38.42
Operating Profit (EBIT)	-31.63	-59.31	-73.94	-129.69	-108.14	-96.44
Other Income	--	--	--	--	1.66	--
Profit before Tax	-31.45	-59.61	-69.78	-123.46	-106.48	-95.40
Provision for Tax	--	--	--	--	-1.20	0.00
Profit after Tax (Net Income)	-31.45	-59.61	-69.78	-123.46	-105.28	-95.40
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-106.48	-95.40

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-36.24	-36.19	14.27	70.67	180.34	210.82
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	24.72	28.10	23.62	20.64	22.27	23.79
Current Liabilities	21.02	21.92	14.54	28.34	23.13	19.81
Total Liabilities	30.53	13.83	52.42	119.66	225.74	254.42

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	5.25	5.82	1.19	3.25	5.31	7.13
Current Assets	4.26	8.01	51.23	116.41	220.43	247.29
Total Assets	13.76	13.83	52.42	119.66	225.74	254.42
Total Debt*	5.86	6.20	0.84	2.46	3.98	5.37
Net Current Assets	--	-13.91	36.69	88.06	197.30	227.48

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-48.20	-71.94	-104.02	-90.42	-62.21
Cash Flow from Investing Activities	--	--	--	-0.10	-0.27	-0.92
Cash from Financing Activities	--	6.28	9.51	0.08	61.21	69.51
Net Cash Inflow / Outflow	--	--	--	--	-29.47	6.37

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-25.70	-50.66	-69.85	-128.53	-119.63	-141.63
Cash EPS ($)	--	-50.34	-68.92	-127.33	-118.26	-139.66
Adjusted Book Value ($)	--	--	14.28	73.57	204.91	312.98
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-40.97	-72.01	-108.28	-102.74	-92.36
Free Cash Flow per Share ($)	--	-40.97	-72.01	-108.38	-103.04	-93.73

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	800.74	-158.16	-95.91	-52.57	-44.70
ROE (%)	--	543.76	-164.30	-98.37	-53.83	-45.34
ROA (%)	-109.42	-179.95	-81.10	-71.49	-43.85	-38.21
EBIT Margin (%)	-345.74	-2,980.35	-634.33	--	--	-38,159.60
Net Margin (%)	-370.05	-2,980.35	-634.33	--	-6,350.00	-38,160.80
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-22.73	-0.82	--	--	-1.00	-0.42
EBIT Growth (%)	50.62	14.57	43.48	-15.95	-11.62	-176.81
Net Profit Growth (%)	47.15	14.57	43.48	-17.27	-10.36	-166.09
EPS Growth (%)	53.28	0.27	0.46	-0.07	0.16	-1.66
Book Value Growth (%)	-52.38	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.01	-0.01	-0.02	-0.07	-0.14
Price / Book Value	2.68	-0.02	0.04	0.03	0.04	0.06
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.31	0.00	0.69	0.87	1.94	2.41
Close Price ($)	4.14	28.39	29.56	123.00	412.50	981.50
High Price ($)	71.50	71.50	201.00	441.00	1,024.50	3,831.50
Low Price ($)	3.12	12.00	28.50	62.00	100.50	936.00
Market Cap ($ Cr)	5.30	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-0.17	0.06	0.03	0.02	0.03
Short term debt to equity ratio	-0.04	-0.04	0.06	0.02	0.01	0.01
Current Ratio	0.20	0.37	3.52	4.11	9.53	12.48
Quick Ratio	0.20	--	--	--	--	--
Interest Coverage	--	--	--	--	-64.22	-31,799.67

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	23.53	--	--	--	--	--
Asset Turnover	0.30	0.06	0.13	--	--	0.00
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	42.81	1,129.51	1,204.04	824.02	11.39
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.